|
ATG16L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.016400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.648600E-01 |
| Normal-vs-Stage2 |
1.844910E-04 |
| Normal-vs-Stage3 |
1.932000E-02 |
| Normal-vs-Stage4 |
9.616200E-02 |
| Stage1-vs-Stage2 |
1.059940E-03 |
| Stage1-vs-Stage3 |
1.017360E-01 |
| Stage1-vs-Stage4 |
3.995200E-01 |
| Stage2-vs-Stage3 |
3.592500E-02 |
| Stage2-vs-Stage4 |
1.520020E-02 |
| Stage3-vs-Stage4 |
5.736400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.267190E-01 |
| Normal-vs-AfricanAmerican |
4.512600E-01 |
| Normal-vs-Asian |
1.108380E-01 |
| Caucasian-vs-AfricanAmerican |
7.648800E-01 |
| Caucasian-vs-Asian |
6.943600E-01 |
| AfricanAmerican-vs-Asian |
5.588000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.848610E-01 |
| Normal-vs-Female |
3.662300E-02 |
| Male-vs-Female |
3.299400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.842800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.271510E-02 |
| Normal-vs-Age(61-80Yrs) |
1.084490E-02 |
| Normal-vs-Age(81-100Yrs) |
1.191230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.760900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.780450E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.469800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.785000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.157000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.380600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.234400E-01 |
| Classical-VS-Follicular |
4.96090000190463E-08 |
| Classical-VS-Other |
3.303800E-01 |
| Classical-VS-Normal |
4.400400E-01 |
| Tall-VS-Follicular |
4.555500E-03 |
| Tall-VS-Other |
4.093800E-01 |
| Tall-VS-Normal |
3.886600E-01 |
| Follicular-VS-Other |
4.245400E-01 |
| Follicular-VS-Normal |
2.04979999999244E-05 |
| Other-VS-Normal |
2.061600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.976990E-03 |
| Normal-vs-N1 |
2.604600E-01 |
| N0-vs-N1 |
1.089400E-01 |
|
|
